Staar Surgical (STAA) FY2014 results: revenue $75 million, up 3.8% on the year
Staar Surgical Co. (STAA) reported revenue of $75 million for fiscal 2014, the year ended 2 January 2015, up 3.8% on the year before. Net income was -$8 million, and diluted earnings per share $-0.22. The figures are the company's own, from the 10-K it filed with the SEC on 13 March 2015.
Revenue
$75 million
+3.8% on the year
FY2009FY2014
Operating margin
-10.7%
1.0% a year earlier
FY2009FY2014
Net income
-$8 million
FY2009FY2014
Diluted EPS
-$0.22
FY2009FY2014
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Revenue
75.0
72.2
63.8
+3.8%
Cost of revenue
26.2
21.9
19.5
+19.4%
Gross profit
48.8
50.3
44.3
-3.0%
Gross margin
65.1%
69.7%
69.4%
Research and development
12.4
6.7
6.4
+84.3%
Operating income
-8.0
0.7
-1.2
Operating margin
-10.7%
1.0%
-1.9%
Interest expense
0.2
0.2
0.3
-9.4%
Pre-tax income
-8.6
1.1
-0.5
Income tax
-0.3
0.7
1.2
Effective tax rate
n/a
64.3%
n/a
Net income
-8.4
0.4
-1.8
Net margin
-11.2%
0.6%
-2.8%
Diluted EPS
-$0.22
$0.01
-$0.05
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Operating cash flow
-8.0
3.4
3.2
Capital expenditure
4.1
3.4
2.3
+17.6%
Free cash flow
-12.0
-0.1
0.9
Free cash flow margin
-16.0%
-0.1%
1.5%
Cash from investing
n/a
n/a
-2.1
Cash from financing
n/a
n/a
4.3
Depreciation and amortisation
2.5
2.2
2.0
+14.4%
Share-based compensation
4.7
4.5
3.2
+3.9%
Diluted shares, weighted
38m
39m
36m
-1.3%
Shares outstanding at period end
38m
38m
36m
+1.4%
Balance sheet
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Shareholders' equity
37.1
38.9
31.7
-4.5%
Debt
4.2
4.8
5.8
-12.6%
Other liabilities
17.7
18.3
17.2
-3.6%
Total liabilities and equity
58.9
61.9
54.8
-4.9%
Fixed assets
10.1
7.4
5.4
+35.9%
Goodwill
1.8
1.8
1.8
0.0%
Intangible assets
0.9
1.4
2.1
-37.0%
Cash and equivalents
13.0
23.0
21.7
-43.3%
Receivables
11.1
10.7
8.5
+3.0%
Inventory
15.7
12.5
11.7
+25.6%
Other assets
6.4
5.2
3.5
+24.1%
Total assets
58.9
61.9
54.8
-4.9%
10-K for the year ended 2 January 2015, filed 13 March 2015: the filing.